Related Experiment Video
Updated: Aug 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Total cardiovascular risk: a new treatment concept
1Department of Medicine, University of Milano-Bicocca Ospedale San Gerardodi Monza, Italy. giuseppe.mancia@uninib.it
Insights
High-risk patients with normal or high-normal blood pressure often have undiagnosed cardiovascular disease. Intensive management of hypertension and other risk factors is crucial for preventing cardiovascular events.
Area of Science:
- Cardiology
- Preventive Medicine
- Clinical Hypertension
Background:
- Cardiovascular risk factors like hypertension, dyslipidemia, and diabetes often coexist.
- Total cardiovascular risk assessment is key in hypertension management guidelines.
- Patients with normal or high-normal blood pressure can still be at high risk due to additional factors.
Purpose of the Study:
- To highlight the importance of identifying and managing high-risk patients often under-diagnosed.
- To emphasize intensive antihypertensive therapy for high-risk individuals.
- To advocate for a multifactorial approach in managing cardiovascular risk.
Main Methods:
- Review of current hypertension management guidelines.
- Analysis of patient profiles with clustered cardiovascular risk factors.
- Discussion of therapeutic strategies for high-risk individuals.
Main Results:
- High-risk patients may present with normal or high-normal blood pressure (130-139/80-89 mmHg).
- These patients often have target-organ damage and associated clinical conditions.
- Intensive therapy, frequently requiring combination drugs, is recommended.
Conclusions:
- Under-diagnosis of high-risk cardiovascular patients is common.
- Multifactorial treatment addressing all reversible risk factors is essential.
- Future research should focus on reversing subclinical damage to prevent cardiovascular risk progression.
Abstract:
Recognition that cardiovascular risk factors, such as hypertension, dyslipidaemia and diabetes mellitus, often cluster together has focused attention on the concept of total cardiovascular risk. Most current hypertension management guidelines emphasize the importance of assessing and managing the total risk in an individual patient. Due to the presence of additional risk factors, target-organ damage and associated clinical conditions, patients may be at high risk of cardiovascular events even when their blood pressure is normal or high-normal (systolic blood pressure 130-139 mmHg, diastolic blood pressure 80-89 mmHg). Such high-risk patients, although common in clinical practice, are often under-diagnosed. Intensive hypertensive therapy is recommended for high-risk patients. In most cases, this will necessitate combination therapy with two or more drugs. Moreover, antihypertensive therapy should form one component of a multifactorial approach aimed at treating all reversible risk factors. In the future, research should be aimed at controlling or reversing subclinical target-organ damage, the ultimate aim being to prevent the progression of cardiovascular risk in individuals at low or medium risk.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease I: Introduction